Change in Body Mass Index and Attributable Risk of New-Onset Hypertension Among Obese Living Kidney Donors
暂无分享,去创建一个
C. Lewis | D. Segev | P. MacLennan | B. Orandi | R. Reed | Vineeta Kumar | J. Locke | G. Roll | C. Schinstock | J. Silkensen | Sydney E Pittman | Andrew G Maynor | Luke A Stanford | Gavin A Baker | M. C. McLeod
[1] A. Matas,et al. Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors , 2021, Journal of the American Society of Nephrology : JASN.
[2] J. Kai,et al. Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK , 2021, BMC Public Health.
[3] T. Cole,et al. Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: A cohort study , 2020, PLoS medicine.
[4] M. Ikram,et al. Do Case-Control Studies Always Estimate Odds Ratios? , 2020, American journal of epidemiology.
[5] Craig M. Hales,et al. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. , 2020, NCHS data brief.
[6] R. Reed,et al. Patient Perspectives on Weight Management for Living Kidney Donation. , 2019, The Journal of surgical research.
[7] A. Garg,et al. Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records , 2019, Clinical transplantation.
[8] J. Friedewald,et al. Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[9] D. Segev,et al. Early Hypertension and Diabetes after Living Kidney Donation: A National Cohort Study. , 2019, Transplantation.
[10] Edward G. Clark,et al. Changes in Body Weight Before and After Kidney Donation , 2019, Canadian journal of kidney health and disease.
[11] A. Matas,et al. Implications of excess weight on kidney donation: Long‐term consequences of donor nephrectomy in obese donors , 2018, Surgery.
[12] D. Segev,et al. Racial differences in completion of the living kidney donor evaluation process , 2018, Clinical transplantation.
[13] B. Kasiske,et al. Temporal trends, center‐level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] Tanjala S. Purnell,et al. The National Landscape of Living Kidney Donor Follow‐Up in the United States , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] A. Israni,et al. The Living Donor Collective: A Scientific Registry for Living Donors , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] A. Garg,et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors , 2017, Transplantation.
[17] C. Lewis,et al. Obesity increases the risk of end-stage renal disease among living kidney donors. , 2017, Kidney international.
[18] C. Lewis,et al. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors , 2017, Annals of surgery.
[19] J. Poorolajal,et al. How much excess weight loss can reduce the risk of hypertension? , 2016, Journal of public health.
[20] R. Plodkowski,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[21] L. F. Junqueira,et al. Male Gender and Body Mass Index Are Associated With Hypertension and Reduced Kidney Function 5 or More Years After Living Kidney Donation. , 2015, Transplantation proceedings.
[22] J. Schold,et al. Critical Factors Associated With Missing Follow‐Up Data for Living Kidney Donors in the United States , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] M. Gulliford,et al. Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. , 2015, American journal of public health.
[24] Tyler J. VanderWeele,et al. A Tutorial on Interaction , 2014 .
[25] A. Garg,et al. Understanding Antihypertensive Medication Use after Living Kidney Donation through Linked National Registry and Pharmacy Claims Data , 2014, American Journal of Nephrology.
[26] S. Saydah,et al. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999‐2010 , 2014, Obesity.
[27] F. Hu,et al. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults , 2014, Obesity.
[28] A. Garg,et al. Medical Outcomes in African American Live Kidney Donors: A Matched Cohort Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] S. Mulgaonkar,et al. Racial Differences in Outcomes of the Evaluation of Potential Live Kidney Donors: A Retrospective Cohort Study , 2012, American Journal of Nephrology.
[30] T. Sairenchi,et al. Long-term stable obesity increases risk of hypertension , 2011, International Journal of Obesity.
[31] M. Schnitzler,et al. Racial variation in medical outcomes among living kidney donors. , 2010, The New England journal of medicine.
[32] A. Matas,et al. Diabetes after Kidney Donation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] H. Assadi,et al. Long-term renal function and cardiovascular disease risk in obese kidney donors. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[34] W. Weimar,et al. Long-term consequences of kidney donation. , 2009, The New England journal of medicine.
[35] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[36] Paul T. Williams. Increases in Weight and Body Size Increase the Odds for Hypertension During 7 Years of Follow‐up , 2008, Obesity.
[37] J. Stevens,et al. Effect of 3‐Year Weight History on Blood Pressure: The Atherosclerosis Risk in Communities Study , 2008, Obesity.
[38] M. Ghoneim,et al. Long‐term follow‐up of living kidney donors: a longitudinal study , 2007, BJU international.
[39] R. D'Agostino,et al. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. , 2005, Archives of internal medicine.
[40] D. Levy,et al. Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression , 2005, Circulation.
[41] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[42] Ralph B D'Agostino,et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.
[43] K. Ishikawa-Takata,et al. Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men , 2002, European Journal of Clinical Nutrition.
[44] V. D’Agati,et al. Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.
[45] I. Okosun,et al. Abdominal obesity in the United States: prevalence and attributable risk of hypertension , 1999, Journal of Human Hypertension.
[46] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[47] W. Kannel,et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham study. , 1967, Annals of internal medicine.
[48] P. MacLennan,et al. Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up , 2018, Transplantation.
[49] W. Rosamond,et al. Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study , 2002, International Journal of Obesity.
[50] S B Hulley,et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.